That’s very interesting and important news Umbriel, with that bit of intel, and looking at Biotron like a hedge fund analyst, we can safely say the HCV endeavour carries no weight with Biotron, adding to this we can also discount HBV endeavour, as Locarnini has done, as far as we can see, absolutely nothing. Moving on them we look at Covid endeavour, this is a real mystery as originally Biotron terminated early trials with BIT225 as it showed zero effect on the Covid virus. This now leaves us with HIV, to date, now one has been remotely interested in BIT225 for some reason.
That’s very interesting and important news Umbriel, with that...
-
- There are more pages in this discussion • 100 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BIT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $17.14M | |||
| Open | High | Low | Value | Volume |
| 1.9¢ | 1.9¢ | 1.9¢ | $7.664K | 403.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 100000 | 1.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.0¢ | 1202498 | 5 |
View Market Depth
| Last trade - 13.42pm 27/09/2024 (20 minute delay) ? |
| BIT (ASX) Chart |